Bayer AG (OTC Pink - Current Information:BAYRY)
| 14.86 Delayed Data As of Jul 30 |  -0.275 / -1.82%Today’s Change | 11.65 Today|||52-Week Range 17.38 | +0.10% Year-to-Date |
Latest BAYRY News | Press Releases
| Bayer Aktiengesellschaft (BAYRY) Upgraded to Buy: Here's What You Should Know Jul 22 / Zacks.com - Paid Partner Content | Lilly (LLY), Incyte's Decision on Olumiant sNDA Delayed by FDA Jul 19 / Zacks.com - Paid Partner Content |
| Merck (MRK) Heart Failure Drug Verquvo Gets Approval in Europe Jul 22 / Zacks.com - Paid Partner Content | Merck (MRK) Gets FDA Nod for Pneumococcal Vaccine Vaxneuvance Jul 19 / Zacks.com - Paid Partner Content |
| Bayer's (BAYRY) Parkinson's Disease Therapy Gets Fast Track Tag Jul 20 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 15.13 |
| Today’s open | 15.02 |
| Day’s range | 14.84 - 15.03 |
| Volume | 337,719 |
| Average volume (3 months) | 363,956 |
| Market cap | $58.4B |
Data as of 07/30/2021
Growth & Valuation
| Earnings growth (last year) | -361.08% |
| Earnings growth (this year) | -8.68% |
| Earnings growth (next 5 years) | +1.73% |
| Revenue growth (last year) | -3.17% |
| P/E ratio | -- |
| Price/Sales | 1.23 |
| Price/Book | 1.56 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | August 5, 2021 |
| EPS forecast (this quarter) | $0.46 |
| Annual revenue (last year) | $47.2B |
| Annual profit (last year) | -$12.0B |
| Net profit margin | -37.61% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Leverkusen, Nordrhein-westfalen |
Forecasts
Chart unavailable
